Ethanol extracts from Ilex pubescens promotes cerebral ischemic tolerance via modulation of TLR4-MyD88/TRIF signaling pathway in rats

• Published in: Journal of ethnopharmacology Vol. 256; p. 112680
• Main Authors: Fang, Xiaoyan, Li, Yujie, Zheng, Yan, Wang, Yanzhi, Feng, Suxiang, Miao, Mingsan
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 28.06.2020
• Subjects: Adaptor Proteins, Vesicular Transport - metabolism; Animals; Anti-Inflammatory Agents - pharmacology; Anti-inflammatory cytokines; Cerebral ischemic tolerance; Cytokines - metabolism; Ethanol - chemistry; Ethanol extracts of Ilex pubescens; Ilex - chemistry; Inflammatory cytokines; Interleukin-10 - metabolism; Ischemic preconditioning; Ischemic Preconditioning - methods; Male; Myeloid Differentiation Factor 88 - metabolism; Neuroprotective Agents - pharmacology; NF-kappa B - metabolism; Plant Extracts - pharmacology; Rats; Rats, Wistar; Reperfusion Injury - drug therapy; Reperfusion Injury - metabolism; Signal Transduction - drug effects; Toll-Like Receptor 4 - metabolism; Tumor Necrosis Factor-alpha - metabolism; Ethanol extracts of Ilex pubescens; Ischemic preconditioning; Inflammatory cytokines; Anti-inflammatory cytokines; Cerebral ischemic tolerance
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2020.112680

Pubescent Holly Root is the dry root of Ilex pubescens Hook. et Arn. It is clinically using in the treatment for stroke and coronary artery disease. It remains unclear whether the ethanol extracts of Ilex pubescens(IPEE) treatment can promote cerebral ischemic tolerance (CIT) and exert endogenous neuroprotective effects and thus to alleviate the nerve injury caused by the subsequent persistent cerebral ischemic attacks. To investigate the effects of IPEE on CIT and its underlying molecular mechanisms. Materials and methods: Adult male Wistar rats were used in the present study. The bilateral common carotid arteries were blocked for 10 min followed a subsequent reperfusion to create the cerebral ischemic preconditioning (CIP); After 3 days post CIP, rats were subjected to middle cerebral artery occlusion/reperfusion (MCAO/R)-injury. Rats were continuously fed with IPEE for 5 days throughout the experiment period at the dose of 100 mg/kg and 200 mg/kg, respectively. Then, the brain infarct volume, histopathology, neurological deficits, and the gene/protein expression related with the TLR4-MyD88/TRIF signaling pathway were evaluated after 24 h of MCAO/R experiment. IPEE pretreatment significantly reduced the cerebral infarct volume, the neurological deficit scores, and the plasma level of neuron specific enolase (NSE) at the dose of 100 mg/kg. Meanwhile, IPEE pretreatment significantly decreased the levels of inflammatory cytokines including TNF-α, IL-6, MCP-1, MIP-1α and RANTES, while it increased the levels of anti-inflammatory cytokines, such as IL-10 and TGF-β, when compared with the group with CIP treatment alone. Moreover, the effect of IPEE treatment on CIT was in a dose-dependent manner, showing as a better effect in the group pretreated with IPEE with the dose of 100 mg/kg than that in group pretreated with IPEE with the dose of 200 mg/kg. In addition, IPEE pretreatment significantly inhibited the expressions of MyD88 mRNA and the protein expression of COX-2 and NF-κBp65, while it strengthened the expressions of TRIF mRNA and protein. The effects of IPEE pretreatment on the expression of these genes were better than that in the group treated with CIP alone. The present study demonstrates that IPEE pretreatment can enhance cerebral ischemic tolerance with a underlying mechanism involved in the toll-like receptor 4 (TLR4) signaling pathway through inhibiting the production of proteins or cytokines in the downstream of MyD88 and activating TRIF dependent anti-inflammatory pathways. [Display omitted]